After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Abbvie Inc is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of Abbvie Inc is $367.55B. A total of 3.46 million shares were traded on the day, compared to an average of 5.62M shares.
In the most recent transaction, Richard A. Gonzalez bought 62,755 shares of ABBV for 210.84 per share on Aug 22 ’25. In a previous transaction on Aug 21 ’25, Richard A. Gonzalez bought 90,000 shares at 211.04 per share.
Among the insiders who sold shares, SALEKI-GERHARDT AZITA disposed of 42,370 shares on Aug 12 ’25 at a per-share price of $198.42. This resulted in the EVP, CHIEF OPERATIONS OFFICER holding 177,292 shares of ABBV after the transaction. In another insider transaction, AZITA SALEKI-GERHARDT bought 42,370 shares at $198.42 per share on Aug 12 ’25.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Abbvie Inc pays an annual dividend of $6.47, resulting in a dividend yield of 3.11%, and it has a price to earnings (P/E) ratio of 99.01.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ABBV has a high of $218.66 and a low of $163.81.
As of this writing, ABBV has an earnings estimate of $3.27 per share for the current quarter. EPS was calculated based on a consensus of 16.0 estimates, with a high estimate of $3.39 per share and a lower estimate of $3.15. The company reported an EPS of $3 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ABBV’s latest balance sheet shows that the firm has $9.83B in Cash & Short Term Investments as of fiscal 2021. There were $76.68B in debt and $35.19B in liabilities at the time. Its Book Value Per Share was -$0.10, while its Total Shareholder’s Equity was $15.44B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABBV is Buy with a score of 4.17.
